A multicentre placebo-controlled clinical trial on the efficacy of oral ciclosporin A in the treatment of canine idiopathic sebaceous adenitis in comparison with conventional topical treatment

Veterinary Dermatology

Volumn 21, Issue 6, 2010, Pages 593-601

  Lortz, Jutta ^a   Favrot, Claude ^b   Mecklenburg, Lars ^c   Nett, Claudia ^a   Rüfenacht, Silvia ^b   Seewald, Wolfgang ^d   Linek, Monika ^e  

^a Die Tierärzte am Grandweg ^*  (Switzerland)

^b VETSUISSE FACULTY UNIVERSITY OF ZURICH   (Switzerland)

^c Independent Veterinary Pathology Consultant   (Germany)

^d NOVARTIS PHARMA AG   (Switzerland)

^e Anicura Tierärztliche Spezialisten Hamburg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DERMATOLOGICAL AGENT;

ALOPECIA; ANIMAL; ANIMAL DISEASE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOG DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SEBACEOUS GLAND; SEBACEOUS GLAND DISEASE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ALOPECIA; ANIMALS; CYCLOSPORINE; DERMATOLOGIC AGENTS; DOG DISEASES; DOGS; DOUBLE-BLIND METHOD; FEMALE; MALE; SEBACEOUS GLAND DISEASES; SEBACEOUS GLANDS; TREATMENT OUTCOME;

CANIS FAMILIARIS;

EID: 78349294199     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2010.00902.x     Document Type: Article

References (34)

1. Rybnicek J, Affolter VK, Moore PF. Sebaceous adenitis: an immunohistological examination. In: Kwochka KW, Willemse T, Tscharner VC, eds. Advances in Veterinary Dermatology, Vol. 3. Oxford, UK: Butterworth Heinemann, 1998: 539-40.
2. Rosser EJ, Dunstan RW, Breen PT. Sebaceous adenitis with hyperkeratosis in the standard poodle: a discussion of 10 cases. Journal of the American Animal Hospital Association 1987; 23: 341-5.
3. Mueller RS, Bettenay SV, Vogelnest LJ. Sebaceous adenitis in three German Shepherd Dogs. Australian Veterinary Practitioner 2001; 31: 110-4.
4. Rosser EJ. Sebaceous adenitis. In: Bongura JD, Kirk RW, eds. Kirk's Current Veterinary Therapy XI. Philadelphia, PA: W.B. Saunders Co, 1992: 534-6.
5. Scott DW, Miller WH, Griffin CE. Sebaceous adenitis. In: Mueller and Kirk's Small Animal Dermatology, 6th edn. Philadelphia, PA: W.B. Saunders Co, 2001: 1140-6.
6. Tevell E, Bergvall K, Egenvall A. Sebaceous adenitis in Swedish dogs, a retrospective study in 104 cases. Acta Veterinaria Scandinavica 2008; 50: 11.
7. Hargis A Sebaceous adenitis. In: Proceedings of the 7th Annual Member Meeting of the AAVD and ACVD. Scottsdale, AZ, 1991. p. 87.
8. Scarff DH. Sebaceous adenitis in standard poodles. Veterinary Record 2000; 146: 476.
9. Reichler IM, Hauser B, Schiller I et al. Sebaceous adenitis in the akita: clinical observations, histopathology and heredity. Veterinary Dermatology 2001; 12: 243-53.
10. Carothers MA, Kwochka KW, Rojko JL. Cyclosporine-responsive granulomatous sebaceous adenitis in a dog. Journal of the American Veterinary Medical Association 1991; 198: 1645-8.
11. Stewart LJ, White SD, Carpenter JL. Isotretinoin in the treatment of sebaceous adenitis of two vizslas. Journal of the American Animal Hospital Association 1991; 27: 65-71.
12. White SD, Rosychuk RA, Scott KV et al. Sebaceous adenitis in dogs and results of treatment with isotretinoin and etretinate: 30 cases (1990-1994). Journal of the American Veterinary Medical Association 1995; 207: 197-200.
13. Suter MM, Tscharner CV Sebadenitis: Die Histopathologie. In: Proceedings, Annual Meeting FK-DVG, 1999.
14. Gross TL, Ihrke PJ, Walder EL et al. Sebaceous adenitis. In: Skin Diseases of the Dog and Cat, 2nd edn. Hoboken, NJ: Wiley-Blackwell, 2005. p. 186-8.
15. Yager JA, Willcock BP, eds. Surgical Pathology of the Dog and Cat. London: Mosby Year Book, 1994; 197-8.
16. Kwochka KW. Retinoids in dermatology. In: Kirk RW, Bonagura JD, eds. Kirk's Current Veterinary Therapy X. Philadelphia, PA: W.B. Saunders Co, 1989: 553-60.
17. Power HT, Ihrke PJ. Synthetic retinoids in veterinary dermatology. Advances in Clinical Dermatology 1990; 20: 1525-39.
18. Rosser EJ. Therapy of sebaceous adenitis. In: Bonagura JD, Kirk RW, eds. Kirk's Current Veterinary Therapy XIII. Philadelphia, PA: W.B. Saunders Co, 2000: 572-3.
19. Marshall C, Williams J. Re-establishment of hair growth, skin pliability and apparent resistance to bacterial infection after dosing fish oil in a dog with sebaceous adenitis. In: Tscharner VC, Halliwell REW, eds. Advances in Veterinary Dermatology, Vol. 1. London, UK: Bailliere Tindall, 1990: 446-7.
20. Linek M, Boss C, Haemmerling R et al. Effects of cyclosporineA on clinical and histologic abnormalities in dogs with sebaceous adenitis. Journal of the American Veterinary Medical Association 2005; 226: 59-64.
21. Sousa CA. Sebaceous adenitis. Veterinary Clinics of North America: Small Animal Practice 2006; 36: 243-9.
22. Cather JC, Abramovits SW, Menter A. Cyclosporin and tacrolismus in dermatology. Dermatology Clinic 2001; 19: 119-37.
23. Guaguère E, Steffan J, Olivry T. Cyclosporin A: a new drug in the field of canine dermatology. Veterinary Dermatology 2004; 15: 61-74.
24. Olivry T, Rivierre C, Jackson HA et al. Cyclosporine decreases skin lesions and pruitus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial. Veterinary Dermatology 2002; 13: 77-87.
25. Robson DC, Burton GG. Cyclosporin, applications in small animal dermatology. Veterinary Dermatology 2003; 14: 1-9.
26. Ho S, Clipstone N, Timmermann L et al. The mechanism of action of cyclosporine A and FK506. Clinical Immunology and Immnuopathology 1996; 80: 40-5.
27. Nousari HC, Anhalt GJ. Immunosuppressive and immunomodulatory drugs. In: Freedberg IM, Eisen AZ, Wolff K et al., eds. Fitzpatrick's Dermatology in General Medicine, 6th edn. New York, NY: The McGraw-Hill Co, 2003: 2448-57.
28. Takahashi T, Kamimura A. Cyclosporin A promotes hair epithelial cell proliferation and modulates protein kinaseC expression and translocation in hair epithelial cells. Journal of Investigative Dermatology 2001; 117: 605-11.
29. Maurer M, Handjiski B, Paus R. Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. American Journal of Pathology 1997; 150: 1433-41.
30. Rosenkrantz WS, Griffin CE, Barr RJ et al. Cyclosporine and cutaneous immune-mediated disease. Journal of American Academic Dermatology 1986; 14: 1088-9.
31. Fontaine J, Olivry T. Treatment of canine atopic dermatitis with cyclosporine: a pilot clinical study. Veterinary Record 2001; 148: 662-3.
32. Seibel W, Yahia NA, McCleary LB et al. Cyclosporine-induced gingival overgrowth in beagle dogs. Journal of Oral Pathology and Medicine 1989; 18: 240-5.
33. Steffan J, Favrot C, Mueller R. A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs. Veterinary Dermatology 2006; 17: 3-16.
34. Rosenkrantz WS. Pemphigus: current therapy. Veterinary Dermatology 2004; 15: 90-8.